Quest Diagnostics (DGX) has been making distinct strides as evidenced by its long-term value stock status, acquisition ventures, and steady share volume trade. Acquisition deals include the procurement of Allina Health, University Hospitals' Outreach Laboratory Services Business, and OhioHealth's Lab Services. As a highlight, it finalized its purchase of LifeLabs, marking a monumental expansion into the Canadian market. The firm's inclusion in the \"Best Place to Work for Disability Inclusion\" for the seventh consecutive year mirrors their commitment to inclusivity. An executive, however, sold $5m of the company's stock. Share performance has remained steady despite this, even outperforming competitors on certain days. The company has raised its 2024 outlook following pleasing Q2 earnings. Quest is also integrating AI and digital pathology vigorously into their systems to accelerate cancer diagnosis. They believe in corporate responsibility and have implemented enhanced education assistance and career growth programs. They have even joined hands with Instacart to address food insecurity issues across the United States.
Quest Diagnostics DGX News Analytics from Thu, 07 Dec 2023 08:00:00 GMT to Sun, 08 Sep 2024 15:33:52 GMT -
